ALIVUS — Alivus Life Sciences Share News
0.000.00%
- IN₹153.54bn
- IN₹145.96bn
- IN₹25.52bn
Brief: Alivus Life Sciences To Buy 76% Stake In Iqgen-X Pharma For Approx 91.2 Million Rupees
India's Alivus rises to 15-month high as brokerages optimistic about drugmaker's annual outlook
India's Alivus Life Sciences rises after quarterly profit increase
Brief: Alivus Life Sciences Ltd March-Quarter Profit 1.63 Billion Rupees
Brief: Alivus Life Sciences Says API Production To Resume March 1
Brief: Alivus Life Sciences Says 3 Injured After Fire At API Plant In Gujarat
India's Alivus Lifesciences posts higher third-quarter profit on API boost
Brief: Alivus Life Sciences Q3 Profit 1.5 Billion Rupees
Brief: Alivus Life Sciences Sept-Quarter Standalone Profit 1.3 Billion Rupees
Brief: Alivus Life Sciences Gets Tax Order Of 12.8 Million Rupees With Penalty 12.9 Million Rupees
Brief: Dev Information Technology Gets 44 Million Rupees Order From Alivus Lifesciences
Brief: Alivus Life Sciences Q4 Profit 1.42 Bln Rupees
Brief: Alivus Life Sciences Says USFDA Issues EIR With VAI Status For Ankleshwar Facility
Brief: Alivus Life Sciences Enters Agreement With Torrent Urja 19
India's Alivus Life Sciences gains on higher Q3 profit
India's Alivus Life posts bigger Q3 profit on API boost
Brief: Alivus Life Sciences Dec-Quarter Profit 1.37 Bln Rupees
India's Glenmark Life gains after Kotak's double upgrade
India's Glenmark Life eyes worst day ever after downbeat Q2 results